Cervical Cancer

05 July 2016

HPV vaccine may help prevent cervical cancer

Young Canadian women who received the HPV vaccine through a school-based programme were less likely to have abnormalities when screened for cervical cancer.

0

The human papillomavirus (HPV) vaccine appears to prevent abnormalities that can lead to cervical cancer, a new study shows.

Pap test results

Canadian researchers found that young women who received the vaccine through a school-based programme were less likely to have such abnormalities when screened for cervical cancer than those who did not receive the vaccine. The young women were screened less than 10 years after they received their first HPV vaccine.

The findings are from the province of Alberta. In 2008, Alberta introduced HPV vaccination for grade 5 girls (aged 10-11) and a three-year catch-up programme for grade 9 girls (aged 14-15). The programme provided three doses of the vaccine that protects against two strains of HPV.

Those two strains of HPV account for 70 percent of all cases of cervical cancer, the researchers said.

Read: What you need to know about HPV vaccination

The study evaluated Pap test results for more than 10,000 women, taken between 2012 and 2015. During a Pap test, cells are collected from the cervix to check for cervical cancer. The women were between 18 and 21 years old.

Among those women, 56 percent had not received HPV vaccination. The remaining 44 percent had received one or more doses of the HPV vaccine through the school programme. About 84 percent of those given the vaccine were considered fully vaccinated. That means they had three or more doses of the vaccine, the researchers noted.

Improved prevention efforts

More than 16 percent of unvaccinated women had cervical abnormalities on a Pap test. Among women who had been fully vaccinated, the rate of cervical abnormalities was 12 percent, the study showed.

Read: 7 facts about HPV

"Eight years after a school-based HPV vaccination programme was initiated in Alberta, three-dose HPV vaccination has demonstrated early benefits, particularly against high-grade cervical abnormalities, which are more likely to progress to cervical cancer," study author Dr Huiming Yang and co-authors wrote. Yang is the medical officer of health, and medical director of screening programmes, for Alberta Health Services.

The researchers said they hope these findings and future research leads to improved prevention efforts. They also suggested that HPV vaccination programmes could be integrated with cervical cancer screening programmes.

The study was published online in the journal CMAJ.

Read more:

When cervical cancer strikes 

Top 10 cervical cancer myths 

10 scary cervical cancer facts

Copyright © 2016 HealthDay. All rights reserved.

 

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst and Head of Advocacy Magdalene Seguin. For more information, visit cansa.org.za.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules